Answers are grounded in this paper and cite their sources.
Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.
No takes yet. Share an insight, caveat, or question.
Shak et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: